Save up -80% on Dapagliflozin
Note: this is a drug discount program, not an insurance plan.
2018 Price of Dapagliflozin
* price without discount in nearest pharmacy. Price may vary.
We offer free Dapagliflozin coupons and discounts that may help you save up to 80% off the retail price in your local pharmacy. Just print your coupon! It’s ready to use and never expire. Present your discount card in most local pharmacies to get a discount on Dapagliflozin every time. What are you waiting for? Claim your prescription drug card now!
Dapagliflozin volume of distribution
Discount Cards 16,000+
Clients Benefit 29%
Total savings $4,735,080
What is Dapagliflozin
Dapagliflozin is indicated for the management of diabetes mellitus type 2, and functions to improve glycemic control in adults when combined with diet and exercise. Dapagliflozin is a sodium-glucose cotransporter 2 inhibitor, which prevents glucose reabsorption in the kidney. Using dapagliflozin leads to heavy glycosuria (glucose excretion in the urine), which can lead to weight loss and tiredness. Dapagliflozin was approved by the FDA on Jan 08, 2014. Dapagliflozin is not recommended for patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.
Dapagliflozin mechanism of action
A competitive inhibitor of the sodium-glucose transport subtype 2 protein, dapagliflozin blocks glucose reabsorption into the kidney, resulting in the elimination of blood glucose through the urine.
Dosage forms of Dapagliflozin
|Film-coated tablet||Oral use||10 mg|
|Film-coated tablet||Oral use||5 mg|
|Tablet, film coated||oral||10 mg/1|
E.R. Squibb – Sons, L.L.C.
Humans and other mammals
Indication of Dapagliflozin
Dapagliflozin is indicated for adjunct management of glycemic control in patients with type 2 diabetes mellitus, in combination with diet and exercise.
Toxicity of Dapagliflozin
Compared to placebo-treated patients, patients with moderate renal impairment treated with dapagliflozin did not have improvement in glycemic control and had more renal-related adverse reactions and more bone fractures; therefore, dapagliflozin should not be initiated in this population. Based on its mechanism of action, dapagliflozin is not expected to be effective in patients with severe renal impairment (eGFR less than 30 mL/min/1.73 m2) or ESRD.
RX24 Drugs Disclaimer: before buying a Dapagliflozin on prescription, consult your healthcare provider. Content on this page is provided for informational purposes only. Any use of this information is at your own risk.